Interneuron-specific signaling evokes distinctive somatostatin-mediated responses in adult cortical astrocytes.
Letizia MariottiGabriele LosiAnnamaria LiaMarcello MeloneAngela ChiavegatoMarta Gómez-GonzaloMichele SessoloSerena BovettiAngelo ForliMicaela ZontaLinda Maria RequieIacopo MarconArianna PuglieseCécile ViolletBernhard BettlerTommaso FellinFiorenzo ContiGiorgio CarmignotoPublished in: Nature communications (2018)
The signaling diversity of GABAergic interneurons to post-synaptic neurons is crucial to generate the functional heterogeneity that characterizes brain circuits. Whether this diversity applies to other brain cells, such as the glial cells astrocytes, remains unexplored. Using optogenetics and two-photon functional imaging in the adult mouse neocortex, we here reveal that parvalbumin- and somatostatin-expressing interneurons, two key interneuron classes in the brain, differentially signal to astrocytes inducing weak and robust GABAB receptor-mediated Ca2+ elevations, respectively. Furthermore, the astrocyte response depresses upon parvalbumin interneuron repetitive stimulations and potentiates upon somatostatin interneuron repetitive stimulations, revealing a distinguished astrocyte plasticity. Remarkably, the potentiated response crucially depends on the neuropeptide somatostatin, released by somatostatin interneurons, which activates somatostatin receptors at astrocytic processes. Our study unveils, in the living brain, a hitherto unidentified signaling specificity between interneuron subtypes and astrocytes opening a new perspective into the role of astrocytes as non-neuronal components of inhibitory circuits.
Keyphrases
- neuroendocrine tumors
- resting state
- white matter
- induced apoptosis
- cerebral ischemia
- cell cycle arrest
- high frequency
- functional connectivity
- spinal cord
- multiple sclerosis
- high resolution
- oxidative stress
- genome wide
- cell death
- gene expression
- brain injury
- neuropathic pain
- subarachnoid hemorrhage
- young adults
- photodynamic therapy
- childhood cancer